ArticleBreast cancer (Tokyo, Japan)2018

Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study.

Yukinori Ozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.